NASH Research Study – Suffolk, VA
Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. The more severe form of NAFLD is called nonalcoholic steatohepatitis (NASH). NASH causes the liver to swell and become damaged. The primary objective of this study is to evaluate the superiority of a combination therapy compared with placebo when administered for 48 weeks in patients with non-cirrhotic NASH with liver fibrosis.
Centricity Research is currently enrolling participants in a NASH research study at our Suffolk, Virginia location. Compensation may be available for time and travel for qualified participants.
- Ages 18 years or more
- NAS greater than or equal to 4 with a score of at least 1 in each component of the NAS (steatosis, lobular inflammation,
and ballooning) at Visit 2 liver biopsy, or a historical liver biopsy performed within 12 weeks of randomization
- Fibrosis stage of 1 or greater and below 4 on NASH CRN fibrosis staging system at
Visit 2 liver biopsy, or a historical liver biopsy performed within 12 weeks of randomization
Study Duration: Up to 64 weeks
Compensation: Up to $1,525 for qualified participants
Location: Centricity Research, 1035 Champions Way #600, Suffolk, VA 23435
You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number K-001-201.
To Learn More, Call Us At 706-321-0495
or Click Here and Someone Will Contact You Shortly!